Answers are grounded in this paper and cite their sources.
The solvent N,N-dimethylformamide (DMF) is widely used in organic synthesis for a broad range of chemical reactions. However, prolonged exposure to DMF presents serious health hazards due to its hepatotoxicity and reproductive toxicity. Growing appreciation of these risks has motivated public and private institutions to phase out the use of DMF and identify safe, viable alternatives for various applications. This is especially urgent for amidation, the most frequently performed reaction class in pharmaceutical organic synthesis, for which DMF is the most frequently used solvent. Existing alternatives to DMF have distinct chemical or practical drawbacks, discouraging widespread adoption. Herein, we identify 3-methyl-2-oxazolidinone (MOX), an unexplored polar aprotic solvent with a favorable chemical, safety, and sustainability profile, as a general replacement for DMF in the synthesis of amides from amines and carboxylic acids. MOX was evaluated in solution-phase amidation reactions for the synthesis of dipeptides, active pharmaceutical ingredients, synthetic auxiliaries, and other structurally or electronically diverse substrates. Across 44 examples employing 23 coupling agents or coupling methods, MOX enabled amidation reactions for a chemically diverse set of substrates through a broad range of reaction conditions. Isolated yields ranged from 43–98%, with a mean yield of 81%. Optimization of reaction conditions was rarely required. These findings establish MOX as a safe and practical replacement for DMF in amidation reactions. Introduction
No takes yet. Share an insight, caveat, or question.
Chennai et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: